February 2, 2026: Brazilian Company May Offer Generic Semaglutide Drugs, Like Rybelsus Hypera, a drug company in Brazil, has announced plans to make a cheaper, generic version of semaglutide in March 2026, when Novo Nordisks patent protections expire in Brazil
After reconstitution, refrigerate at 28 C, avoid repeated freezethaw cycles, and use within laboratory defined timeframes
Nat Metab
Verify 2026 coverage: Don't assume your plan will cover Zepbound next yearcheck during open enrollment Get documentation ready: Prepare weight history, comorbidities, and prior medication trials Budget for alternatives: LillyDirect cash pricing is available now
Rarely other unexpected effects of semaglutide are reported, including acute cholecystitis, paralysis of the abducens nerve, and positional vertigo [105]
Producing it in a clandestine lab would be extremely costly, says Margraf